A Phase 4 interventional study of Ceftaroline in Open Fractures, sponsored by Olayemi Osiyemi MD. Status unknown at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-10-28.
Sponsored by Olayemi Osiyemi MD · Phase 4, Interventional, and Treatment
Prospective look at antibiotic prophylaxis with Ceftaroline in patients with type II and III open fractures
Determine if antibiotic prophylaxis with Ceftaroline in patients with type II and III open fractures is a safe and effective alternative to standard combination therapy
53 studies on the registry are indexed under Fractures, Open; 14 are open to participants now.
This study's planned enrollment of 50 is below the median of 90 across 40 interventional studies indexed under Fractures, Open.
Browse Fractures, Open studies →Olayemi Osiyemi MD is the lead sponsor of 3 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Every patients will receive Ceftaroline in an open label, single arm
Drug: Ceftaroline
IV Ceftaroline will be given for 72 hours
Also known as: Teflaro
Rate of fracture site infection at 30 days between ceftaroline and historical hospital rate
Time frame: 30 days
Incidence of acute kidney injury
Time frame: 30 days
Identify bacteria associated with the infections
Time frame: 30 days
identify the number of infections associated with sites other than fracture site
Time frame: 30 days
Plan to share: Yes — no personal data, identifier and the data are made available
No publications or documents are linked to this record.
This study is status unknown, as verified in Oct 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Ceftaroline
Olayemi Osiyemi MD